In this blog we look at a number of Brexit information resources for the pharmaceutical sector.
In this blog Brian Cleary looks at the efforts by some members of the British government to remain an active part of the European Medicines Agency.
In this blog, Brian Cleary looks at clinical trials and Brexit. He also looks at the issues surrounding the UK’s departure from the European Union.
The Acorn Regulatory Brexit team has worked with a wide variety of companies over the last 18 months. These companies have sought out the expertise that the Acorn Regulatory Brexit team has in matters related to the UK’s decision to leave the EU. In that time, our specialists have also produced a number of whitepapers […]
The European Medicines Agency has had to dedicate considerable resources in dealing with the complex issues related to the UK’s decision to leave the European Union. In this article we look at one of the main questions highlighted by the EMA relating to UK Marketing Authorisation Holders and provide additional resources to assist you in better […]